Valuation (14%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.01 | N/A |
| PEG Ratio (TTM) | N/A | N/A |
| P/S Ratio (TTM) | 0.57 | N/A |
| P/B Ratio (TTM) | 4.07 | N/A |
| P/FCF Ratio (TTM) | -1.89 | N/A |
| Price to 5YR AVG Earnings Ratio | -0.01 | N/A |
| Price to 5YR AVG FCF Ratio | -23.87 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -14,993.75% | N/A |
| ROE (TTM) | -59,727.08% | N/A |
| Net Profit Margin (TTM) | -5,338.08% | N/A |
| ROIC 5YR AVG | 399.34% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -17,716.62% | 42.56% | -41.05% |
| Revenue | 23,163.64% | -8.66% | -31.97% |
| Net Income | -19,412.67% | -38.92% | -178,876.84% |
| Cash Flow | 16.27% | -57.60% | -77.96% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.54 | N/A |
| Quick Ratio (TTM) | 3.54 | N/A |
| D/E Ratio (TTM) | 438.19 | N/A |
| Interest Coverage (TTM) | -3,501.70 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -2.46 | N/A |
| Shares Outstanding Growth 5YR AVG | 116.63% | N/A |